Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
- Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
- Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
- Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
- PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
Observed in differential profiles
- G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Control_vs_nsPEF_7_day
- G1_PBS_vs_G2_DSS
- Sham_vs_Radiofrequency
- Normal_vs_Neural_Tube_Defect
- Control_vs_CSD
- Control_vs_ZYP_High_Dose
- Male_19_days_vs_Male_1_day
- Control_0d_vs_Treatment_180d
- wild_type_vs_patA_deletion